MarketsandMarkets estimates that, in the US, dietary supplements will claim a $167.5 billion market in 2023. Over half of American adults — along with more than a third of American children — take at least one supplement.
These supplements make big promises, and the public has bought in. Unfortunately, they are not delivering, which is why xNARA claims the failure of dietary supplements lies in the medical community’s one-size-fits-all approach to health for the past century.
“Because every person is unique, one bottle of pills will never be able to address the health needs of an entire population,” says Dr. Rafi Ahmad, xNARA’s Chief R&D Officer. “We share things in common, but variations in our genetic makeup, diet, environment, and lifestyle mean that our bodies are built differently. At xNARA, we utilize a nutrition quiz, DNA assessment, and gut profile test to capture a holistic overview of your unique health needs. We analyze the results and tailor a formula targeting the specific disease risks and health issues arising from your individual genetics and microbiome imbalances.”
A groundbreaking personalized health supplement
Individual health needs and wellness goals vary widely, but for over a century, medicine addressed these unique needs with blanket prescriptions and generic pills. In 2020, xNARA launched to change this approach.
Today, the company operates offices in Singapore, Dubai, and Austin. To deliver supplements capable of targeting each person’s diverse needs with clinically based treatments, the xNARA team utilized 324,000 hours of research and development. They spent three years collaborating with world-renowned experts from trusted institutions such as Harvard and Johns Hopkins.
This dedication to scientific precision has earned them the trust and endorsement of renowned figures in the industry. By looking at each person’s biology, lifestyle, and overall health, the xNARA team can determine his or her exact nutritional needs. The combination of…
Read the full article here
